The role of photodynamic therapy in the treatment of recurrent superficial bladder cancer

Urologic Clinics of North America

Volumn 27, Issue 1, 2000, Pages 163-170

  Walther, McClellan M ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOSENSITIZING AGENT;

BLADDER CANCER; CANCER RECURRENCE; CARCINOMA IN SITU; CLINICAL RESEARCH; HEMATURIA; HUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SENSITIZATION; SUNBURN; TREATMENT OUTCOME;

EID: 0033960179     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70244-5     Document Type: Article

References (65)

1. R. Baghdassarian M.W. Wright S.A. Vaughn The use of lipid emulsion as an intravesical medium to disperse light in the potential treatment of bladder tumors J Urol 133 1985 126 130
2. A. Barel G. Jori A. Perin Role of high-, low- and very low-density lipoproteins in the transport and tumor delivery of hematoporphyrin in vivo Cancer Lett 32 1986 145 150
3. D.A. Bellnier Y.K. Ho R.K. Pandey Distribution and elimination of Photofrin II in mice Photochem Photobiol 50 1989 221 228
4. R.C.J. Benson G.M. Farrow J.H. Kinsey Detection and localization of in situ carcinoma of the bladder with hematoporphyrin derivative Mayo Clin Proc 57 1982 548 555
5. R.C. Benson Jr Integral photoradiation therapy of multifocal bladder tumors Eur Urol 12 suppl 1 1986 47 53
6. A. Blum L.I. Grossweiner Singlet oxygen generation by hematoporphyrin IX, uroporphyrin I and hematoporphyrin derivative at 546 nm in phosphate buffer and in the presence of egg phosphatidylcholine liposomes Photochem Photobiol 41 1985 27 32
7. D.G. Boyle W.R. Potter Photobleaching of photofrin II as a means of eliminating skin photosensitivity Photochem Photobiol 46 1987 997 1001
8. P.J. Bugelski C.W. Porter T.J. Dougherty Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse Cancer Res 41 1981 4606 4612
9. M.A. D'Hallewin L. Baert Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder Urology 45 1995 763 767
10. M.A. D'Hallewin L. Baert J.P. Marijnissen Whole bladder wall photodynamic therapy with in situ light dosimetry for carcinoma in situ of the bladder J Urol 148 1992 1152 1155
11. T.F. Delaney E. Glatstein Photodynamic therapy of cancer Compr Ther 14 1988 43 55
12. M. Dugan E. Crawford U.O. Nseyo A randomized trial of observation (OBS) versus photodynamic therapy (PDT) after transurethral presection (TUR) for superficial papillary bladder cancer [abstract 554] Proceedings of American Society of Clinical Oncology 10 1991 173
13. I. Freitas Role of hypoxia in photodynamic therapy of tumors Tumori 71 1985 251 259
14. G.C. Goyal A. Blum L.I. Grossweiner Photosensitization of liposomal membranes by hematoporphyrin derivative Cancer Res 43 1983 5826 5830
15. L.I. Grossweiner Membrane photosensitization by hematoporphyrin and hematoporphyrin derivative Prog Clin Biol Res 170 1984 391 404
16. L.I. Grossweiner G.C. Goyal Photosensitized lysis of liposomes by hematoporphyrin derivative Photochem Photobiol 37 1983 529 532
17. Harrington FS, Manyak MJ: Patent No. 4,867,404. Flexible Holder for a Cystoscope of the Like. 1989
18. J.I. Harty M. Amin T.J. Wieman Complications of whole bladder dihematoporphyrin ether photodynamic therapy J Urol 141 1989 1341 1346
19. W. Hausmann Die Sensibilisierende Wirkung Tierischer Farbstoffe und ihre Physiologische Bedeutung Wien Klin Wochenschr 21 1908 1527 1529
20. H. Hisazumi N. Miyoshi K. Naito Whole bladder wall photoradiation therapy for carcinoma in situ of the bladder: A preliminary report J Urol 131 1984 884 887
21. H. Hisazumi K. Naito T. Uchibayashi Integral photodynamic therapy of superficial bladder tumors with special reference to carcinoma in situ Scand J Urol Nephrol Suppl 138 1991 161 165
22. N. Javadpour Photodynamic therapy Tis and T1 transitional carcinoma of the bladder Progress in Clinical Research 303 1989 471 478
23. D. Jocham M. Beer R. Baumgartner Long-term experience with integral photodynamic therapy of TIS bladder carcinoma Ciba Foundation Symposium 146 1989 198 205
24. G. Jori L. Tomio E. Reddi Preferential delivery of liposome-incorporated porphyrins to neoplastic cells in tumour-bearing rats Br J Cancer 48 1983 307 309
25. H. Kato T. Horai K. Furuse Photodynamic therapy for cancers: A clinical trial of porfimer sodium in Japan Jpn J Cancer Res 84 1993 1209 1214
26. J.F. Kelly M.E. Snell Hematoporphyrin derivative: A possible aid in the diagnosis and therapy of carcinoma of the bladder J Urol 115 1976 150 151
27. J.E. Klaunig S.H. Selman J.R. Shulok Morphologic studies of bladder tumors treated with hematoporphyrin derivative photochemotherapy Am J Pathol 119 1985 236 243
28. M. Kreigmair R. Waidelich W. Lumper Integral photodynamic treatment of refractory superficial bladder cancer J Urol 154 1995 1339 1341
29. M. Kriegmair R. Baumgartner R. Knuechel Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid Urology 44 1994 836 841
30. M. Kriegmair R. Baumgartner W. Lumper Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer Br J Urol 77 1996 667 671
31. M. Kriegmair R. Waidelich R. Baumgartner Photodynamic therapy of superficial bladder cancer: An alternative to radical cystectomy? Urologe A 33 1994 276 280
32. J.H. Li Z.H. Guo M.L. Jin Photodynamic therapy in the treatment of malignant tumours: An analysis of 540 cases J Photochem Photobiol B 6 1990 149 155
33. R.L. Lipson E.J. Baldes The photodynamic properties of a particular hematoporphyrin derivative Arch Dermatol 82 1960 508 516
34. R.L. Lipson M.J. Gray E.J. Baldes Hematoporphyrin derivative for detection and management of cancer 1966 Proceedings of the Ninth International Cancer Congress Tokyo, Japan 393
35. M.J. Manyak Photodynamic therapy: Principles and urological applications Semin Urol 9 1991 192 202
36. M.J. Manyak J.W. Cole R.J. McNellis Downstaging of BCG-resistant carcinoma in situ of the bladder by photodynamic therapy with intravesical diffusion medium [abstract 648] J Urol 147 1992 374A
37. M.J. Manyak J.W. Cole P.D. Smith Whole bladder photodynamic therapy: Enhancement of light distribution from laser optical fibers through the use of diffusion medium J Urol 143 1990 81A
38. M.J. Manyak F.S. Harrington E. Glatstein A flexible cystoscope holder/surgical retractor that really works J Urol 138 1987 105 106
39. M.J. Manyak P.D. Smith F.S. Harrington Protection against dihematoporphyrin ether photosensitivity Photochem Photobiol 47 1988 823 830
40. J.P. Marijnissen W.M. Star in Z.H. In situ light dosimetry during whole bladder wall photodynamic therapy: Clinical results and experimental verification Phys Med Biol 38 1993 567 582
41. J.P. Marynissen H. Jansen W.M. Star Treatment system for whole bladder wall photodynamic therapy with in vivo monitoring and control of light dose rate and dose J Urol 142 1989 1351 1355
42. J.C. Maziere P. Morliere R. Santus The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours J Photochem Photobiol B 8 1991 351 360
43. J.B. Mitchell S. McPherson W. DeGraff Oxygen dependence of hematoporphyrin derivative-induced photoinactivation of Chinese hamster cells Cancer Res 45 1985 2008 2011
44. J. Moan S. Sommer Action spectra for hematoporphyrin derivative and Photofrin II with respect to sensitization of human cells in vitro to photoinactivation Photochem Photobiol 40 1984 631 634
45. K. Naito H. Hisazumi T. Uchibayashi Integral laser photodynamic treatment of refractory multifocal bladder tumors J Urol 146 1991 1541 1545
46. U.O. Nseyo Photodynamic therapy Urol Clin North Am 19 1992 591 599
47. U.O. Nseyo J. DeBord H. Kim Sequential whole bladder photodynamic therapy treatments: A preclinical study Urol Oncol 3 1997 27 30
48. U.O. Nseyo J. DeHaven T.J. Dougherty Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: A long-term experience J Clin Laser Med Surg 16 1998 61 68
49. U.O. Nseyo B. Shumaker E.A. Klein Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder: Bladder Photofrin Study Group J Urol 160 1998 39 44
50. H.I. Pass Photodynamic therapy in oncology: Mechanisms and clinical use J Natl Cancer Inst 85 1993 443 456
51. A. Policard Etude sur les Aspects Offerts par des Tumeurs Experimentales Examinees a la Lumiere de Wood C R Soc Bio (Paris) 91 1924 1423 1424
52. J.G. Post P.J. te Y. Oussoren The influence of intravesical photodynamic therapy on subsequent bladder irradiation tolerance Radiother Oncol 37 1995 124 130
53. G.R. Prout Jr C.W. Lin R. Benson Jr Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder N Engl J Med 317 1987 1251 1255
54. O. Raab Uber die Wirkung Fluorescirender Stoffe auf Infusorien Z Biol 39 1900 524 546
55. B.P. Shumaker F.W. Hetzel Clinical laser photodynamic therapy in the treatment of bladder carcinoma Photochem Photobiol 46 1987 899 901
56. B.P. Shumaker M.D. Lutz G.P. Haas Practical clinical use of laser photodynamic therapy in the treatment of bladder carcinoma in situ Lasers Med Sci 1 1986 257 261
57. M.E. Tian Photodynamic therapy with hematoporphyrin derivative for transitional-cell carcinoma of the urinary bladder—report of 30 cases Chung Hua Chung Liu Tsa Chih 11 1989 304 306
58. A. Tsuchiya N. Obara M. Miwa Hematoporphyrin derivative and laser photoradiation in the diagnosis and treatment of bladder cancer J Urol 130 1983 79 82
59. T. Uchibayashi K. Koshida K. Kunimi Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder Br J Cancer 71 1995 625 628
60. R. Waidelich A. Hofstetter H. Stepp Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors J Urol 159 1998 401 404
61. Walther MM, Delaney TF, Harrington F, et al: Patent No. 5,505,687,575,751. Device for Measuring Incident Light in a Body Cavity. 1996
62. M.M. Walther T.F. Delaney P.D. Smith Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder Urology 50 1997 199 206
63. M.M. Walther E.D. Eanes T.F. Delaney Bladder calcifications after photodynamic therapy: Analysis of a rare complication Urology 47 1996 831 835
64. K.R. Weishaupt C.J. Gomer T.J. Dougherty Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor Cancer Res 36 1976 2326 2329
65. T. Windahl L.A. Lofgren Two years' experience with photodynamic therapy of bladder carcinoma Br J Urol 71 1993 187 191